FDA - Cybersecurity Vulnerabilities Identified in St. Jude Medical's Implantable Cardiac Devices

Posted on Jan 9, 2017 12:46:58 PM

The U.S. Food and Drug Administration (FDA) released a safety communication regarding cybersecurity vulnerabilities reported in St. Jude Medical's implantable cardiac devices as well as corresponding Merlin@home transmitters. This communication was in response to research that was verified by Bishop Fox, which indicated that the devices were exploitable.

St. Jude Medical has issued a software patch in tandem with the FDA statement.




Submit a Media Request

Please get in touch with our PR Team for any press or PR related inquiries.

Email: contact@bishopfox.com


Subscribe to Updates